Effect of Prophylactic Levosimendan on All-Cause Mortality in Pediatric Patients Undergoing Cardiac Surgery—An Updated Systematic Review and Meta-Analysis
Background: Levosimendan, a calcium sensitizer, enhances the myocardial function by generating more energy-efficient myocardial contractility than that achieved through adrenergic stimulation with catecholamines. We conducted this meta-analysis to primarily investigate the effects of levosimendan on...
Main Authors: | Hongbai Wang, Qipeng Luo, Yinan Li, Liang Zhang, Xie Wu, Fuxia Yan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-08-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fped.2020.00456/full |
Similar Items
-
Successful use of levosimendan as a primary inotrope in pediatric cardiac surgery: An observational study in 110 patients
by: Reena Khantwal Joshi, et al.
Published: (2016-01-01) -
Clinical efficacy of levosimendan vs milrinone in preventing low cardiac output syndrome following pediatric cardiac surgery
by: Kaushik Jothinath, et al.
Published: (2021-01-01) -
Preservation of renal function in cardiac surgery patients with low cardiac output syndrome: levosimendan vs beta agonists
by: Jose Luis Guerrero Orriach, et al.
Published: (2019-11-01) -
Influence of timing of Levosimendan administration on outcomes in cardiac surgery
by: Fridtjof Schiefenhövel, et al.
Published: (2023-07-01) -
LEVOSIMENDAN FOR INTENSIVE THERAPY OF HEART FAILURE IN HEART VALVE PROSTHETICS
by: O. N. Ulitkina, et al.
Published: (2016-02-01)